Abstract

Recent studies have revealed that the microbiota may be implicated in diabetes-related cognitive dysfunction. However, the relationship between gut microbiota and cognitive dysfunction during the progression of type 2 diabetes remains elusive. We used 16S rRNA sequencing combined with conventional behavioral tests to explore the longitudinal changes of gut microbiota and cognition in diabetic db/db mice (leptin receptor knockout mice) and their wild-type littermates at different ages. Prussian blue staining was performed to detect the microhemorrhage in the brain, and immunofluorescent study was applied to analyze microglia activation. Moreover, a Meso Scale Discovery kit was used to determine the cytokine levels in the brain. Db/db mice exhibited age dependent pathological characteristics, including cognitive deficits, neuron damage, spontaneous hemorrhages and neuroinflammation. Furthermore, we observed that the diversity and composition of gut microbiota significantly differed between the wild-type and db/db mice during aging. We found that compared to age-matched wild-type mice, genus Helicobacter was significant higher in db/db mice at 18 and 26 weeks. Correlation analysis revealed that Helicobacter is positively associated with Iba-1 positive cells and TNF-α expression. Collectively, our longitudinal study suggests that diabetic cognitive impairment during aging is associated with abnormal gut microbiota composition, which may play a role in the regulation of neuroinflammation.

Highlights

  • Type 2 diabetes (T2DM) is a chronic metabolic disorder and its prevalence is on the rise throughout the world

  • Given the potential role of gut microbiota in diabetes-related cognitive dysfunction, we undertook a comprehensive study to investigate the longitudinal changes of gut microbiota in db/db mice, a typical T2DM rodent model, using 16S ribosomal RNA sequencing combined with conventional behavioral tests and pathological analysis

  • We investigated the longitudinal changes of gut microbiota and cognition in db/db mice from an early age, using 16S ribosomal RNA sequencing combined with conventional behavioral tests

Read more

Summary

Introduction

Type 2 diabetes (T2DM) is a chronic metabolic disorder and its prevalence is on the rise throughout the world. It causes serious complications in various organs, including the central nervous system (Zhao et al, 2019). Diabetes-related cognitive dysfunction is manifested as decreased learning and memory, weakened executive ability, and emotional disturbance. Considering the prevalence of T2DM, diabetes-related cognitive dysfunction will inevitably bring arduous challenges and an immeasurable economic burden to social public health. It is imperative to explore the underlying pathogenesis of cognitive dysfunction caused by diabetes, and new strategies to delay or reduce the occurrence of the disease are needed

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call